LTA Antikörper (AA 1-205)
-
- Target Alle LTA Antikörper anzeigen
- LTA (Lymphotoxin-alpha (LTA))
-
Bindungsspezifität
- AA 1-205
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LTA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit polyclonal antibody raised against a full-length human LTA protein.
- Sequenz
- MTPPERLFLP RVRGTTLHLL LLGLLLVLLP GAQGLPGVGL TPSAAQTARQ HPKMHLAHST LKPAAHLIGD PSKQNSLLWR ANTDRAFLQD GFSLSNNSLL VPTSGIYFVY SQVVFSGKAY SPKATSSPLY LAHEVQLFSS QYPFHVPLLS SQKMVYPGLQ EPWLHSMYHG AAFQLTQGDQ LSTHTDGIPH LVLSPSTVFF GAFAL
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
- Immunogen
- LTA (AAH34729.1, 1 a.a. ~ 205 a.a) full-length human protein.
- Top Product
- Discover our top product LTA Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Targeted inhibition of phosphatidyl inositol-3-kinase p110?, but not p110?, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers." in: Apoptosis : an international journal on programmed cell death, Vol. 18, Issue 4, pp. 509-20, (2013) (PubMed).
: "
-
Targeted inhibition of phosphatidyl inositol-3-kinase p110?, but not p110?, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers." in: Apoptosis : an international journal on programmed cell death, Vol. 18, Issue 4, pp. 509-20, (2013) (PubMed).
-
- Target
- LTA (Lymphotoxin-alpha (LTA))
- Andere Bezeichnung
- LTA (LTA Produkte)
- Substanzklasse
- Chemical
- Hintergrund
-
Full Gene Name: lymphotoxin alpha (TNF superfamily, member 1)
Synonyms: LT,TNFB,TNFSF1 - Gen-ID
- 4049
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-